Skip to main content

Advertisement

SpringerLink
Log in

Control of inflammation with alpha1-antitrypsin: A potential treatment for islet transplantation and new-onset type 1 diabetes

  • Invited Commentary
  • Published:
Current Diabetes Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Ogawa N, List JF, Habener JF, Maki T: Cure of overt diabetes in NOD mice by transient treatment with anti-lymphocyte serum and exendin-4. Diabetes 2004, 53:1700–1705.

    Article  PubMed  CAS  Google Scholar 

  2. Chatenoud L, Primo J, Bach JF: CD3 antibody-induced dominant self tolerance in overtly diabetic NOD mice. J Immunol 1997, 158:2947–2954.

    PubMed  CAS  Google Scholar 

  3. Keymeulen B, Vandemeulebroucke E, Ziegler AG, et al.: Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes. N Engl J Med 2005, 352:2598–2608.

    Article  PubMed  CAS  Google Scholar 

  4. Herold KC, Gitelman SE, Masharani U, et al.: A single course of anti-CD3 monoclonal antibody hOKT3gamma1(Ala-Ala) results in improvement in C-peptide responses and clinical parameters for at least 2 years after onset of type 1 diabetes. Diabetes 2005, 54:1763–1769.

    Article  PubMed  CAS  Google Scholar 

  5. Huurman VA, Hilbrands R, Pinkse GG, et al.: Cellular islet autoimmunity associates with clinical outcome of islet cell transplantation. PLoS ONE 2008, 3:e2435.

    Article  PubMed  Google Scholar 

  6. Brantly ML, Wittes JT, Vogelmeier CF, et al.: Use of a highly purified alpha 1-antitrypsin standard to establish ranges for the common normal and deficient alpha 1-antitrypsin phenotypes. Chest 1991, 100:703–708.

    Article  PubMed  CAS  Google Scholar 

  7. Breit SN, Wakefield D, Robinson JP, et al.: The role of alpha 1-antitrypsin deficiency in the pathogenesis of immune disorders. Clin Immunol Immunopathol 1985, 35:363–380.

    Article  PubMed  CAS  Google Scholar 

  8. Churg A, Dai J, Zay K, et al.: Alpha-1-antitrypsin and a broad spectrum metalloprotease inhibitor, RS113456, have similar acute anti-inflammatory effects. Lab Invest 2001, 81:1119–1131.

    PubMed  CAS  Google Scholar 

  9. Song S, Goudy K, Campbell-Thompson M, et al.: Recombinant adeno-associated virus-mediated alpha-1 antitrypsin gene therapy prevents type I diabetes in NOD mice. Gene Ther 2004, 11:181–186.

    Article  PubMed  CAS  Google Scholar 

  10. Lewis EC, Shapiro L, Bowers OJ, Dinarello CA: Alpha1-antitrypsin monotherapy prolongs islet allograft survival in mice. Proc Natl Acad Sci U S A 2005, 102:12153–12158.

    Article  PubMed  CAS  Google Scholar 

  11. Lewis EC, Mizrahi M, Toledano M, et al.: alpha1-Antitrypsin monotherapy induces immune tolerance during islet allograft transplantation in mice. Proc Natl Acad Sci U S A 2008, 105:16236–16241.

    Article  PubMed  CAS  Google Scholar 

  12. Zhang B, Lu Y, Campbell-Thompson M, et al.: Alpha 1 antitrypsin protects ta-cells from apoptosis. Diabetes 2007, 56:1316–1323.

    Google Scholar 

  13. Koulmanda M, Bhasin M, Hoffman L, et al.: Curative and beta cell regenerative effects of alpha1-antitrypsin treatment in autoimmune diabetic NOD mice. Proc Natl Acad Sci U S A 2008, 105:16242–16247.

    Article  PubMed  CAS  Google Scholar 

  14. Bruning JC, Winnay J, Bonner-Weir S, et al.: Development of a novel polygenic model of NIDDM in mice heterozygous for IR and IRS-1 null alleles. Cell 1999, 88:561–572.

    Article  Google Scholar 

  15. Butler AE, Janson J, Bonner-Weir S, et al.: Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 2003, 52:102–110.

    Article  PubMed  CAS  Google Scholar 

  16. Koulmanda M, Budo E, Bonner-Weir S, et al.: Modi-fication of adverse inflammation is required to cure new-onset type 1 diabetic hosts. Proc Natl Acad Sci U S A 2007, 104:13074–13079.

    Article  PubMed  CAS  Google Scholar 

  17. Crystal RG: Alpha 1-antitrypsin deficiency, emphysema, and liver disease. Genetic basis and strategies for therapy. J Clin Invest 1990, 85:1343–1352.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Section on Islet Transplantation and Cell Biology, Joslin Diabetes Center, One Joslin Place, Boston, MA, 02215, USA

    Gordon C. Weir

Authors
  1. Gordon C. Weir
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Maria Koulamnda
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gordon C. Weir.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Weir, G.C., Koulamnda, M. Control of inflammation with alpha1-antitrypsin: A potential treatment for islet transplantation and new-onset type 1 diabetes. Curr Diab Rep 9, 100–102 (2009). https://doi.org/10.1007/s11892-009-0018-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11892-009-0018-5

Keywords

Search

Navigation